In an interdisciplinary team at Washington University, we are proposing ways to improve the FDA approval process. Our first editorial was recently published.
Michele Boldrin and S. J. Swamidass. A new bargain for drug approvals. Wall Street Journal, July 2011.
In the September 2010 issue of Science this article was cited in the lead editorial, Rethinking Clinical Trials.